Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut
NCT02457416 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2016-05-04
Summary
The purpose of the study is to identify prognostic markers and possible success rate of tolerance induction to peanut allergens in children allergic to peanut.
Conditions
- Food Hypersensitivity
Interventions
- OTHER
-
Peanut
Treatment with peanut in increasing doses until a maintenance dose
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Principal Investigators
-
Geir Håland, MD PhD · Oslo University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- Norway
Study Locations
More Related Trials
-
Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
NCT02194530 ·Status: COMPLETED
-
The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
NCT02271620 ·Status: COMPLETED ·Phase: NA
-
Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
NCT03703791 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
NCT03755713 ·Status: COMPLETED ·Phase: PHASE1
-
Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets
NCT06554691 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)
NCT01699165 ·Status: COMPLETED ·Phase: NA
-
Management of Drug Hypersensitivity in Children
NCT02031120 ·Status: TERMINATED
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Long Term Effect of AIT in Children
NCT06421415 ·Status: RECRUITING
-
Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
NCT01451450 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis
NCT02409563 ·Status: COMPLETED ·Phase: PHASE4
-
Nut Allergy Study: Double-blind Challenge and Oral Desensitization
NCT01502878 ·Status: COMPLETED ·Phase: NA
-
Nasal Provocation Testing in Occupational Rhinitis
NCT01436851 ·Status: COMPLETED ·Phase: NA
-
Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects
NCT05476497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficiency And Tolerance Of Hazelnut Oral Immunotherapy Protocol In Hazelnut Allergic Children
NCT04841850 ·Status: COMPLETED
-
Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
NCT04004351 ·Status: COMPLETED
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract
NCT00927329 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
NCT04957927 ·Status: UNKNOWN ·Phase: PHASE4
-
Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT
NCT01987817 ·Status: COMPLETED ·Phase: PHASE2
-
Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases
NCT00815984 ·Status: COMPLETED
-
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
NCT00578929 ·Status: COMPLETED ·Phase: PHASE3
-
Low Dose Multi-Nut Oral Immunotherapy in Pre-schoolers With a Multi-Nut Allergy
NCT05049512 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization
NCT01625715 ·Status: UNKNOWN ·Phase: PHASE2
-
Oral Immunotherapy for Peanut Allergic Patients
NCT04163562 ·Status: RECRUITING ·Phase: PHASE1/PHASE2